<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="28771" whole_study_id="28771" phs="001572" v="1" p="1" createDate="2018-04-02T13:44:37-05:00" completedByGPADate="2018-04-02T13:56:19-05:00" modDate="2020-02-03T01:53:50-05:00" maxParentChildStudyModDate="2020-02-03T01:53:50-05:00" handle="PD1" num_participants=""><StudyInfo accession="phs001572.v1.p1" parentAccession="phs001572.v1.p1"><BioProject id="PRJNA449579" entrez_id="449579" type="bp_admin_access"/><BioProject id="PRJNA449580" entrez_id="449580" type="bp_data_submission"/><StudyNameEntrez>Pan-tumor genomic biomarkers for personalization of PD-1 checkpoint blockade based immunotherapy</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Razvan" lname="Cristescu" email="razvan_cristescu@merck.com"><Role>PI</Role><Organization/></Person><Person nedid="FOX_MERCK_SO" aid="2" auth="eRA" login="FOX_MERCK_SO" fname="Caroline" mname="" lname="Fox" email="caroline.fox@merck.com"><Role>PI_ASSIST</Role><Organization>MERCK AND COMPANY</Organization></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work has been funded by Merck and Co.  We gratefully acknowledge the patients and their families, the investigators and site personnel who participated in the KEYNOTE-001,-006,-012 and -028 studies.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2974" CGType="cg_class_DS" title="Disease-Specific (Cancer, IRB)" name="DS-CA-IRB" dac_uid="59" dac_name="NCI DAC" irb-approval-required="Yes"><Use-Restriction>Use of the data must be related to Cancer.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>